Oxford scientists believe they could have breakthrough on Covid-19 vaccine – Telegraph

Ross J Burland FXStreet

Oxford scientists believe they could have a breakthrough on Covid-19 vaccine, which is reported in the Telegraph today.

Key notes

The clinical trials have so far been successful, the Telegraph understands.
Researchers have shown that antibodies produced against sections of a genetic material called spike protein, usually found on the surface of the coronavirus, after infection are able to kill the virus when tested in the laboratory.
They want the human body to recognise and develop antibodies to the protein that would stop the virus from entering human cells.
Trials suggest that not only is this happening but also that the body is developing a crucial T-cell response as well, which is deemed crucial in the defence against coronavirus.

When will it be available?

The article states that AstraZeneca is on track to begin rolling out up to two billion doses of a coronavirus vaccine in September if ongoing trials continue to prove successful.

What is the next step?

As the level of coronavirus in the UK subsided, scientists began trialling the drug in hospitals, where it was likely to be more prevalent.

They have also enrolled 5,000 volunteers in Brazil and others in South Africa.

Developers are expected to report their Phase I study results - which would show whether it is safe and whether or not it induces an immune response - within the next fortnight.

Market implications

"Bring it on!", say the bulls.

Author

Ross J Burland

FXStreet

Ross J Burland, born in England, UK, is a sportsman at heart. He played Rugby and Judo for his county, Kent and the South East of England Rugby team.

AUD/USD stuck as the RBA talks tough into a slowdown

The Australian Dollar is going nowhere in a hurry, and the contradiction at its core explains why. The Reserve Bank of Australia keeps dangling the prospect of another hike, yet the economy it governs just expanded 0.3% in the first quarter, a clear step down from the prior pace. A central bank threatening to tighten into a visible slowdown is not a recipe for conviction in either direction, and the tape shows it.

USD/JPY: Japanese Yen coiled at the line, leaning on everyone but Japan

The Yen is doing very little, and that stasis is the whole story. USD/JPY sits glued near 160.00 not because Japan has found new strength, but because two outside forces are fighting to a draw over it: a US rate complex that keeps the dollar bid, and a Ministry of Finance that refuses to let the line break.

Gold declines below $4,500 on stalled US-Iran ceasefire talks, US NFP data looms

Gold price edges lower to near $4,470 during the early Asian session on Friday. The precious metal remains volatile amid ongoing geopolitical turmoil. Traders will closely monitor the developments surrounding the US-Iran peace deal and the US May employment report later on Friday.

Bitcoin falls below $64K as demand turns negative, short-term holders' selling intensifies

Bitcoin has fallen below $64,000 on Thursday amid weakening market demand and mounting selling pressure from short-term holders. The leading cryptocurrency slipped toward the $63,000 level amid a broader risk-off environment, with several key metrics signaling one of the most challenging periods of the current market cycle.

Nonfarm payrolls: Testing the limits of Fed policy patience

The upcoming nonfarm payrolls report for May will provide the final update on the US labor market before Kevin Warsh attends his first policy meeting as the new Fed Chair later this month.

Recession on paper: What really moves the Canadian Loonie now?

Statistics Canada handed the headline writers a gift and the analysts a headache. Real GDP shrank 0.1% on an annualized basis in the first quarter, and with the fourth quarter of 2025 revised down to a 1.0% contraction, that is two negative quarters in a row, the textbook definition of a technical recession and Canada's first since the pandemic.